The Global Trial Accelerators™ podcast delivers actionable insights for Medtech and Biopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
🎙️ New Episode of LATAM Medtech Leaders with Javier Handal 🎙️ In this episode, we have the pleasure of speaking with Javier Handal, a Medical Doctor with extensive experience in clinical research and pharmaceutical industry operations. As the leader of MRx Solution, a Site Management Organization …
Javier Handal is a Medical Doctor with expertise in clinical research and pharmaceutical industry operations. As the leader of MRx Solution, a Site Management Organization (SMO), he is driving the development of a robust netw...
Today, we have the privilege of speaking with Andrew, a distinguished leader with over 15 years of international experience in marketing, commercial excellence, and business strategy. Throughout his career, he has led large teams at top pharmaceutical and medical device companies, including Novarti…
Today, we have the privilege of speaking with Andrew, a distinguished leader with over 15 years of international experience in marketing, commercial excellence, and business strategy. Throughout his career, he has led large t...
In this episode of LATAM Medtech Leaders, we sit down with Daniel Estay, a seasoned medical technology executive with a wealth of global experience. Daniel shares insights from his journey leading and developing fully integrated businesses across small, mid-sized, and large companies. With extensiv…
In this episode of LATAM Medtech Leaders , we sit down with Daniel Estay , a seasoned medical technology executive with a wealth of global experience. Daniel shares insights from his journey leading and developing fully integ...
CEO, bioaccess®
Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech and Biopharma innovation by positioning Latin America (and more recently Eastern Europe, and Australia) as a global leader in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.